Claris Lifesciences today said its consolidated net profit rose by 8.49% to Rs 141.44 crore for the year ended December 31, 2010, over the same period last fiscal.
The company had reported a net profit of Rs 130.36 crore in the same period previous fiscal, Claris Lifesciences said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company rose to Rs 626.68 crore for the period, compared to Rs 627.78 crore in the same period previous fiscal.
The company's board, which met today, also proposed a dividend of Rs 2 per share of of Rs 10 each for the financial year ended December 31, 2010.
Shares of Claris Lifesciences closed today at Rs 189.20 on the BSE, up 1.99% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app